Tuesday, 16 June 2026
  
Login

Australia's most trusted
source of pharma news

Tuesday, 16 June 2026
Ascott 2
Ascott 2
10 arrivals bump Review List to 46

The number of new medicines currently under evaluation in Australia has jumped to 46 after the TGA accepted an additional 10 type A applications.

Long-timers heading out the door
In the last three weeks, Australian pharma has lost employees with almost 150 years of combined experience. See the latest exits
TODAY
NZ raising the bar to... average
Medicines industry body embarks on awareness campaign with the embarrassing truth that 'average' would be a win
TODAY
Medscape
Medscape
Which pharma pays the most?
The numbers are in, revealing which Big Pharma pays its workforce the biggest salaries... and which don't
15 June
Global high-flyer moving to Aust
This international value and access executive is relocating to Australia with his family... and he's looking for work
15 June
Gloves off in High Court battle
New player in make-or-break court case to decide the exclusivity period of a swath of PBS-listed products
15 June
Monster CEO-worker pay gap
Which CEO earns 358 times more than the median employee at his company topping the pay gap list for the second year?
12 June
ADG PRIME
ADG PRIME
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (22)

Access & Reimbursement (1)

Clinical & Medical, R&D (8)

Regulatory, Pharmacovigilance & QA (4)

Executive Roles (9)

Other (9)

Ethics of pharma profits debated
Big name drugs under scrutiny by an Aussie panel unpacking the ethics and impact of private and public funding
15 June
TGA registers three new drugs
There is new hope for some rare disease sufferers with the ARTG-listing of three innovative treatments
15 June Approvals Action
PBS drug bows out after 35 years
First registered for use in Australia in 1991, this drug is being discontinued but there is no reimbursed alternative
12 June
Pharma faces record revenue hit
ICYMI: One of the biggest patent cliff falls in pharma history looms plus the other most popular stories this week
12 June Your Week in 5 Minutes
Excellence in Life Sciences gonged
Seven people walked awa with Awards after being recognised for excellence in the healthcare sector
12 June
New competency pillar unveiled
Peak industry body updates its Core Competency Framework, adding a new domain to underpin all of the Code
12 June
Pharma boss breaks Aussie house record
Smashes house record in Victoria with a $136M purchase that comes with a mansion and entire apartment block
11 June
Pharma drops $39M on meetings
The latest transparency reports show the pharmaceutical industry spent tens of millions of dollars in third-party support
11 June
US biotech lands T cell drug in Aust
US biotech enters the Australian market with the TGA approving the first T cell therapy for solid tumour cancer
11 June
PBAC Chair lays it all on the table
In a free-flowing conversation at ARCS, Robyn Ward offered frank views on a wide range of topics, including HTA reform
11 June
Industry body unveils name change
After 40 years, a new identity that better reflects members' professional standing and the organisation's expanding role
11 June
Is this pharma's toughest job?
More is being asked of these pharma professionals than ever before in an increasingly complex landscape
10 June
On a roll: Arrotex signs new deal
Local giant seizes the ANZ rights to an innovative anti-seizure drug, signing a deal with a Korean pharma
10 June
Record turnout for ARCS conference
Pharma professionals have descended on Sydney's International Convention Centre for the 2026 ARCS conference which kicked off today
10 June
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.